Literature DB >> 19437562

FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging.

Feng Ji1, Xi Jin, Chun-Hua Jiao, Qin-Wei Xu, Zi-Wei Wang, Yue-Liang Chen.   

Abstract

AIM: To investigate the role of FAT10 and mutant p53 in the pathogenesis, severity and prognosis of gastric cancer.
METHODS: FAT10, mutant p53 mRNA and protein levels were measured by reverse transcription (RT)-PCR and immunohistochemistry in gastric cancer tissue (n = 62), tumor-adjacent tissue (n = 62) and normal gastric tissue (n = 62). Relation of FAT10 and mutant p53 expression with clinicopathological features and clinical outcomes of gastric cancer patients were analyzed.
RESULTS: The FAT10, mutant p53 mRNA and protein levels were significantly higher in gastric cancer than in its adjacent and normal tissue. The FAT10 and mutant p53 levels in gastric cancer tissue were significantly correlated with lymph node metastasis and tumor, nodes, metastasis (TNM) staging. Moreover, the high FAT10 level was associated with the overall survival rate of patients. Multivariate Cox-proportional hazards model analysis showed that mRNA and protein levels of FAT10 and mutant p53, lymph node metastasis, distant metastasis and TNM stage were the independent prognostic factors for gastric cancer.
CONCLUSION: FAT10 may be involved in gastric carcinogenesis, and is a potential marker for the prognosis of gastric cancer patients. FAT10 and mutant p53 may play a common role in the carcinogenesis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437562      PMCID: PMC2682237          DOI: 10.3748/wjg.15.2228

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2.

Authors:  Y C Liu; J Pan; C Zhang; W Fan; M Collinge; J R Bender; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Identification of seven new human MHC class I region genes around the HLA-F locus.

Authors:  W Fan; W Cai; S Parimoo; D C Schwarz; G G Lennon; S M Weissman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 3.  p53--an acrobat in tumorigenesis.

Authors:  U M Moll; L M Schramm
Journal:  Crit Rev Oral Biol Med       Date:  1998

Review 4.  The role of p53-target genes in human cancer.

Authors:  T Tokino; Y Nakamura
Journal:  Crit Rev Oncol Hematol       Date:  2000-01       Impact factor: 6.312

5.  The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location.

Authors:  M Rugge; Y H Shiao; G Busatto; M Cassaro; C Strobbe; V M Russo; G Leo; A R Parenti; A Scapinello; P Arslan; E Egarter-Vigl
Journal:  Mol Pathol       Date:  2000-08

Review 6.  Regulation of p53 downstream genes.

Authors:  W S el-Deiry
Journal:  Semin Cancer Biol       Date:  1998       Impact factor: 15.707

7.  The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis.

Authors:  S Raasi; G Schmidtke; M Groettrup
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

8.  Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.

Authors:  Caroline G L Lee; Jianwei Ren; Ian S Y Cheong; Kenneth H K Ban; London L P J Ooi; Soo Yong Tan; Alison Kan; Issarang Nuchprayoon; Rongxian Jin; Kang-Hoe Lee; Michael Choti; Linda A Lee
Journal:  Oncogene       Date:  2003-05-01       Impact factor: 9.867

9.  The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract.

Authors:  Eiji Oki; Yan Zhao; Rintaro Yoshida; Akinori Egashira; Kippei Ohgaki; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Digestion       Date:  2009-01-20       Impact factor: 3.216

10.  FAT10, a gene up-regulated in various cancers, is cell-cycle regulated.

Authors:  Chuan-Bian Lim; Dongwei Zhang; Caroline G L Lee
Journal:  Cell Div       Date:  2006-09-08       Impact factor: 5.130

View more
  15 in total

1.  Increased expression of FAT10 is correlated with progression and prognosis of human glioma.

Authors:  Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Liang Wang; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Pathol Oncol Res       Date:  2012-03-09       Impact factor: 3.201

2.  The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Andrew Lin; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-04-28       Impact factor: 3.362

3.  Increased FAT10 expression is related to poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Guo-Hui Sun; Ying-Di Liu; Guo Yu; Nan Li; Xiao Sun; Jing Yang
Journal:  Tumour Biol       Date:  2014-02-04

4.  Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms.

Authors:  Xin Qing; Babara A French; Joan Oliva; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-10-01       Impact factor: 3.362

5.  FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC.

Authors:  Yue Zhang; Zhifan Zuo; Bo Liu; Pinghua Yang; Jun Wu; Lei Han; Tao Han; Tingsong Chen
Journal:  J Gastrointest Oncol       Date:  2021-08

6.  Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.

Authors:  Bin Dai; Yisong Zhang; Peng Zhang; Changcun Pan; Cheng Xu; Weiqing Wan; Zhen Wu; Junting Zhang; Liwei Zhang
Journal:  Tumour Biol       Date:  2016-01-06

7.  NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53.

Authors:  Yongwook Choi; Jong Kyoung Kim; Joo-Yeon Yoo
Journal:  Mol Oncol       Date:  2014-01-24       Impact factor: 6.603

8.  Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.

Authors:  Meng Zhang; Feifei Cui; Su Lu; Huijun Lu; Tao Jiang; Jian Chen; Xuemei Zhang; Yubiao Jin; Zhihai Peng; Huamei Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.

Authors:  Jian Chen; Huamei Tang; Zehua Wu; Chongzhi Zhou; Tao Jiang; Yingming Xue; Guoyu Huang; Dongwang Yan; Zhihai Peng
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

10.  Ubiquitin-Like Protein UBD Promotes Cell Proliferation in Colorectal Cancer by Facilitating p53 Degradation.

Authors:  Hongbin Su; Mengdi Qin; Qiang Liu; Bo Jin; Xianjun Shi; Zheng Xiang
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.